Vulnerability Description
Philips ISCV application prior to version 2.3.0 has an insufficient session expiration vulnerability where an attacker could reuse the session of a previously logged in user. This vulnerability exists when using ISCV together with an Electronic Medical Record (EMR) system, where ISCV is in KIOSK mode for multiple users and using Windows authentication. This may allow an attacker to gain unauthorized access to patient health information and potentially modify this information.
CVSS Score
MEDIUM
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Philips | Intellispace Cardiovascular | <= 2.3.0 |
Related Weaknesses (CWE)
References
- http://www.securityfocus.com/bid/102847Third Party AdvisoryVDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-025-01MitigationThird Party AdvisoryUS Government Resource
- https://www.usa.philips.com/healthcare/about/customer-support/product-securityMitigationVendor Advisory
- http://www.securityfocus.com/bid/102847Third Party AdvisoryVDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-025-01MitigationThird Party AdvisoryUS Government Resource
- https://www.usa.philips.com/healthcare/about/customer-support/product-securityMitigationVendor Advisory
FAQ
What is CVE-2018-5438?
CVE-2018-5438 is a vulnerability with a CVSS score of 6.3 (MEDIUM). Philips ISCV application prior to version 2.3.0 has an insufficient session expiration vulnerability where an attacker could reuse the session of a previously logged in user. This vulnerability exists...
How severe is CVE-2018-5438?
CVE-2018-5438 has been rated MEDIUM with a CVSS base score of 6.3/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2018-5438?
Check the references section above for vendor advisories and patch information. Affected products include: Philips Intellispace Cardiovascular.